We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

96 hedge funds and large institutions have $288M invested in Lifecore Biomedical in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 32 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

13% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 32

9% more capital invested

Capital invested by funds: $265M → $288M (+$23.3M)

0% more funds holding

Funds holding: 96 → 96 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.55% less ownership

Funds ownership: 93.34% → 90.79% (-2.6%)

62% less call options, than puts

Call options by funds: $10K | Put options by funds: $26K

Holders
96
Holders Change
–
Holders Change %
0%
% of All Funds
1.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
36
Reduced
32
Closed
8
Calls
$10K
Puts
$26K
Net Calls
-$16K
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$6.35M
2
CSC
Cove Street Capital
California
+$4.74M
3
N
Nuveen
North Carolina
+$3.43M
4
AC
AltraVue Capital
Washington
+$2.19M
5
BlackRock
BlackRock
New York
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
-$14.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$4.2M
3
WC
Walthausen & Co
New York
-$1.14M
4
WPC
White Pine Capital
Minnesota
-$1.07M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$804K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$2.21M +$958K +92,699 +83%
Boston Partners
27
Boston Partners
Massachusetts
$2.2M -$591K -57,185 -22%
Morgan Stanley
28
Morgan Stanley
New York
$2.01M -$508K -49,190 -21%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$1.93M -$9.81K -950 -0.5%
Fuller & Thaler Asset Management
30
Fuller & Thaler Asset Management
California
$1.89M -$94.5K -9,145 -5%
Charles Schwab
31
Charles Schwab
California
$1.82M -$35.3K -3,413 -2%
Millennium Management
32
Millennium Management
New York
$1.4M +$509K +49,267 +62%
TAM
33
Tocqueville Asset Management
New York
$1.33M – – –
Norges Bank
34
Norges Bank
Norway
$1.14M – – –
CIP
35
Chartwell Investment Partners
Pennsylvania
$946K -$28.9K -2,794 -3%
Squarepoint
36
Squarepoint
New York
$927K +$269K +26,025 +44%
Wells Fargo
37
Wells Fargo
California
$877K +$10.6K +1,025 +1%
RA
38
Royce & Associates
New York
$820K – – –
JP Morgan Chase
39
JP Morgan Chase
New York
$803K +$608K +58,829 +390%
Jacobs Levy Equity Management
40
Jacobs Levy Equity Management
New Jersey
$785K +$248K +24,013 +50%
PCM
41
Perritt Capital Management
Illinois
$739K -$207K -20,000 -23%
AA
42
Ancora Advisors
Ohio
$697K -$26.9K -2,600 -4%
Bank of America
43
Bank of America
North Carolina
$678K -$117K -11,358 -15%
Swiss National Bank
44
Swiss National Bank
Switzerland
$650K – – –
Citadel Advisors
45
Citadel Advisors
Florida
$638K +$607K +58,795 New
Invesco
46
Invesco
Georgia
$622K +$29K +2,807 +5%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$582K -$11.4K -1,100 -2%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$570K +$129K +12,454 +31%
WPC
49
White Pine Capital
Minnesota
$558K -$1.07M -103,142 -67%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$499K +$56.2K +5,437 +13%
1
2
3 4 5

LFCR Hedge Fund Activity: Q4 2020 in Review

96 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q4 2020, worth a combined $288M — up 8.8% from $265M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new LFCR positions and 8 closed out — a net gain of 1 holder — while 36 added to existing stakes and 32 trimmed.

The largest buyer was Kennedy Capital Management, adding an estimated $6.35M. The largest seller was Russell Investments Group, cutting an estimated $14.4M.

  • 96 institutional investors held Lifecore Biomedical (LFCR) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $288M of Lifecore Biomedical stock for Q4 2020, up 8.8% quarter-over-quarter.
  • 9 funds opened new Lifecore Biomedical positions in Q4 2020 and 8 closed out, a net change of +1 holder.
  • The largest Lifecore Biomedical buyer in Q4 2020 was Kennedy Capital Management, an estimated $6.35M added.
  • The largest Lifecore Biomedical seller in Q4 2020 was Russell Investments Group, an estimated $14.4M sold.

Based on aggregated 13F filings for Q4 2020.